Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.
Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Anaplastic Lymphoma,ALK +ve Metastatic NSCLC
NSCLC -ROS 1 +,NTRK+
Locally Advanced or metastatic Urothelial Carcinoma
Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory B-Cell precursor ALL
CML(Philadelphia chromosome +ve)
mCRC,metastatic Melanoma with BRAF Mutation
Relapsed or refractory Marginal Zone Lymphoma
Medullary Thyroid Cancer(Unresectable Locally Advanced or metastatic)
Diffuse Large B-Cell Lymphoma or LBCL
EPITHELIAL OVARIAN CA,FALLOPIAN CA,PRIMARY PERITONEAL CA
Multiple Myeloma
metastatic Basal Cell Carcinoma
metastatic NSCLC (With EGFR exon 20 insertion mutations)
Relapsed or Refractory Peripheral T-Cell Lymphoma
Chronic Phase CML
Relapsed or Refractory AML
mNSCLC with no EGFR,ALK +VE Mutations
Myelofibrosis
NSCLC With High PD-L1
Adrenal carcinoma and inoperable adrenal cortical carcinoma
metastatic HER 2 +VE Breast cancer who hv received 2 prior anti HER 2 Regimens
Unresectable or metastatic melanoma
Relapsed or refractory Diffuse large B CELL lymphoma
AML CD33 +VE
metastatic NSCLC,1ST line locally advanced with cisplatin and Adv BC
Extended adjuvant early stage HER 2 amplified Breast cancer
Multiple myeloma
Locally advanced Basel cell carcinoma
GLIOMA
Postmenopausal ER+VE,HER 2-VE locally adv or mBC
Locally advanced or metastatic urothelial cancer
Locally advanced or metastatic cholangiocarcinoma
GIST
Advanced or metastatic RET fusion +ve thyroid cancer
Relapsed or Refractory Leukemia With KMT2A Translocation
ROS 1+VE mNSCLC
mNSCLC EGFR exon 20 insertion mutations
Multiple Myeloma
KRAS G12C mutated mNSCLC
CASTLEMANs DISEASE
metastatic epithelioid sarcoma not eligible for complete resection
Relapsed or Refractory AML with a susceptible IDH mutation
mTNBC
HR+,HER 2 -VE BC
HER 2 +ve mBC who hv recd atlease 2 prior anti HER 2 regimens
High risk Neuroblastoma
CLL or SLL(Small Lymphocytic Lymphoma
Overdose of Flurocil or Capecitabine
t-AML OR AML-MRC (myelodysplasia related changes)
Relapsed or refractory Diffuse large B CELL lymphoma
mSCLC
Cutaneous T-Cell Lymphoma (CTCL)
folicular B cell NHL
